Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonistClaudine Serradeil-Le Gal, Jean Wagnon, Jacques Simiand, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2002
SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing propertiesPaul C Moser, Olivier E Bergis, Samir Jegham, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repairBadia Ferzaz, Emmanuel Brault, Genevieve Bourliaud, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 27, 2007
Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disordersJeanne Stemmelin, Caroline Cohen, Jean-Paul Terranova, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 7, 2003
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profileYves Claustre, Danielle De Peretti, Philippe Brun, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2004
SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm laborClaudine Serradeil-Le Gal, Gérard Valette, Loïc Foulon, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterizationDanielle Gully, Michel Geslin, Laurence Serva, et al.
Pharmacology, Biochemistry, and Behavior|July 16, 2008
Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophreniaDenis Boulay, Philippe Pichat, Gihad Dargazanli, et al.
Hepatology (Baltimore, Md.)|May 26, 2007
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa ratsMagali Gary-Bobo, Ghizlane Elachouri, Jean François Gallas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 16, 2005
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychoticRonan Depoortère, Gihad Dargazanli, Genevieve Estenne-Bouhtou, et al.
Pageof 3